ISSN 0300-9092 (Print)
ISSN 2412-5679 (Online)

Evaluation of the accuracy of a prognostic model for the risk of fetal macrosomia

Tysyachny O.V., Romanov A.Yu., Baev O.R., Grebenshchikova L.Yu.

1) Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, Moscow, Russia; 2) I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University), Moscow, Russia; 3) Tver State Medical University, Ministry of Health of Russia, Tver, Russia

The Fetal Medicine Foundation (FMF) has demonstrated that the risk of having a large baby and/or fetal macrosomia can be predicted based on screening data in the first trimester. Numerous models for predicting fetal macrosomia have been described in contemporary scientific literature. However, due to the limited effectiveness, these predictive models are not used in clinical practice. Given that fetal macrosomia is associated with a high risk of adverse obstetric and neonatal outcomes, it is important to estimate the value of the prediction model for the birth of a large fetus created by the FMF.
Objective: To explore the discriminatory ability and prognostic value of the FMF prediction model for large for gestational age fetus. 
Materials and methods: We conducted a retrospective validation cohort study. It included 600 participants who were divided into two groups. The main group (n=300) consisted of women who gave birth to large for gestational age babies (baby’s weight equal to or over the 90th percentile). The comparison group (n=300) included women who gave birth to babies weighing between the 10th and the 90th percentiles. Large for gestational age was defined when birth weight was equal to the 90th percentile for their gestational age.  
Results: We identified the differences in the values of weight, height and the PAPP-A levels (MoM) in the examined women (p<0.0001 and p=0.02), that were higher in group I (fetal macrosomia). ROC analysis showed a moderate ability of the model to distinguish between the patients with a high and low risk of developing macrosomia:  AUC of 0.66, sensitivity – 59.68%, specificity – 56.82%, positive predictive value – 49.33%, negative predictive value – 66.67%, and accuracy – 58%.
Conclusion: Our study explored the discriminatory ability of the FMF model and its predictive value for having large for gestational age babies in the population of the Russian women. Analysis of the calibration curve showed that the model is characterized by satisfactory preservation of relative risks, but requires baseline risk adjustment. We believe that the differences in prediction accuracy are due to application of this model in different populations.

Authors' contributions: Tysyachny O.V. –  study concept and design, data collection and analysis; Romanov A.Yu.  – statistical analysis; Baev O.R. – manuscript editing; Grebenshchikova L.Yu – manuscript writing. 
Conflicts of interest: The authors declare that they have no conflicts of interest.
Funding: The study was carried out without any sponsorship.
Ethical Approval: The study was approved by the local Ethics Committee of V.I. Kulakov National Medical Research Center 
for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia.
Patient Consent for Publication: The patients have signed informed consent for participation in the study and publication of their data.
Authors' Data Sharing Statement: The data supporting the findings of this study are available on request from the corresponding author after approval from the principal investigator.
For citation: Tysyachny O.V., Romanov A.Yu., Baev O.R., Grebenshchikova L.Yu. 
Evaluation of the accuracy of a prognostic model for the risk of fetal macrosomia.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2026; (3): 68-74 (in Russian)
https://dx.doi.org/10.18565/aig.2025.309

Keywords

large fetus for gestational age
fetal macrosomia
large fetus

References

  1. Magee L.A., Brown M.A., Hall D.R., Gupte S., Hennessy A., Karumanchi S.A. et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022; 27: 148-69. https://dx.doi.org/10.1016/j.preghy.2021.09.008
  2. www.fetalmedicine.org/research/assess/macrosomia
  3. Chagovets V., Frankevich N., Starodubtseva N., Tokareva A., Derbentseva E., Yuryev S. et al. Early prediction of fetal macrosomia through maternal lipid profiles. Int. J. Mol. Sci. 2025; 26(3): 1149. https://dx.doi.org/10.3390/ijms26031149
  4. Lu Q., Guo Z., Zhang J., Wang K., Tian Q., Liu S. et al. Performance of whole-genome promoter nucleosome profiling of maternal plasma cell-free DNA for prenatal noninvasive prediction of fetal macrosomia: a retrospective nested case-control study in mainland China. BMC Pregnancy Childbirth. 2022; 22(1): 698. https://dx.doi.org/10.1186/s12884-022-05027-w
  5. Du J., Zhang X., Chai S., Zhao X., Sun J., Yuan N. et al. Nomogram-based risk prediction of macrosomia: a case-control study. BMC Pregnancy Childbirth. 2022; 22(1): 392. https://dx.doi.org/10.1186/s12884-022-04706-y
  6. Yuan Y., Zhu Q., Yao X., Shi Z., Wen J. Maternal circulating metabolic biomarkers and their prediction performance for gestational diabetes mellitus related macrosomia. BMC Pregnancy Childbirth. 2023; 23(1): 113. https://dx.doi.org/10.1186/s12884-023-05440-9
  7. Leona C.Y., Karagiannis G., Stratieva V., Syngelaki A., Nicolaides K.H. First-trimester prediction of macrosomia. Fetal Diagn. Ther. 2011; 29(2): 139-47. https://dx.doi.org/10.1159/000318565
  8. Giouleka S., Tsakiridis I., Ralli E., Mamopoulos A., Kalogiannidis I., Athanasiadis A. et al. Diagnosis and management of macrosomia and shoulder dystocia: a comprehensive review of major guidelines. Obstet. Gynecol. Surv. 2024; 79(4): 233-41. https://dx.doi.org/10.1097/OGX.0000000000001253
  9. Bair C.A., Cate J., Chu A., Kuller J.A., Dotters-Katz S.K. Nondiabetic fetal macrosomia: causes, outcomes, and clinical management. Obstet. Gynecol. Surv. 2024; 79(11): 653-64. https://dx.doi.org/10.1097/OGX.0000000000001326
  10. Faul F., Erdfelder E., Lang A.-G., Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007; 39(2): 175-91. https://dx.doi.org/10.3758/BF03193146
  11. Министерство здравоохранения Российской Федерации. Клинические рекомендации. Нормальная беременность. М.; 2020. 80 с. [Ministry of Health of the Russian Federation. Clinical guidelines. A normal pregnancy. Moscow; 2020. 80 p. (in Russian)].
  12. Stevens R.J., Poppe K.K. Validation of clinical prediction models: what does the “calibration slope” really measure? J. Clin. Epidemiol. 2020; 118: e93-9. https://dx.doi.org/10.1016/j.jclinepi.2019.09.016
  13. Середа А.П., Андрианова М.А. Рекомендации по оформлению дизайна исследования. Травматология и ортопедия в России. 2019; 25(3): 165-84. [Sereda A.P., Andrianova M.A. Study design guidelines. Traumatology and orthopedics of Russia. 2019; 25(3): 165-84. (in Russian)]. https://dx.doi.org/10.21823/2311-2905-2019-25-3-165-184

Received 28.10.2025

Accepted 12.02.2026

About the Authors

Oleg V. Tysyachny, PhD, Researcher at the 1st Maternity Department, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology,
Ministry of Health of Russia, 117997, Russia, Moscow, Oparina str., 4, o_tysyachny@oparina4.ru, https://orcid.org/ 0000-0001-9282-9817
Andrey Yu. Romanov, PhD, Head of the Department of Planning and Support of Scientific Projects, V.I. Kulakov National Medical Research Center for Obstetrics,
Gynecology and Perinatology, Ministry of Health of Russia, 117997, Russia, Moscow, Oparina str., 4, romanov1553@yandex.ru
Oleg R. Baev, Dr. Med. Sci., Professor, Head of the 1st Maternity Department, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia, 117997, Russia, Moscow, Oparina str., 4; Professor at the Department of Obstetrics, Gynecology, Perinatology, and Reproductology,
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, o_baev@oparina4.ru, https://orcid.org/0000-0001-8572-1971
Lyudmila Yu. Grebenshchikova, PhD, Head of the Department of Reproductive Medicine and Perinatology, Tver State Medical University, Ministry of Health of Russia;
General Director, Medical Center «Consilium», 170039, Russia, Tver, Pozharnaya sqr., 3, +7(4822)368550, ludmilazdrav@mail.ru, klinika.concilium@mail.ru,
https://orcid.org/0000-0003-2815-1882

Similar Articles